Table 2. Population at risk and numbers of cases infected and with clinical manifestations by endemicity level for 2030.

Absolute numbers (N and DALYs) are presented in thousands.

	Hypoendemic			Mesoendemic			Hyperendemic			Very hyperendemic
	N	%	DALYs	N	%	DALYs	N	%	DALYs	N	%	DALYs
Total population at risk	145,846	100	-	67,483	100	-	18,053	100	-	4,721	100	-
Mf-positive	4,299	2.9	-	1,237	1.8	-	692	3.8	-	585	12.4	-
Mf-positive (age 5+)	4,299	2.9	-	1,237	1.8	-	691	3.8	-	585	12.4	-
Adult female worm infection	8,735	6.0	-	3,326	4.9	-	2,083	11.5	-	1,432	30.3	-
Palpable nodules	482	0.3	5	419	0.6	4	281	1.6	3	231	4.9	2
Severe itch	353	0.2	64	107	0.2	19	56	0.3	10	26	0.5	5
Reactive skin disease	89	0.1	4	23	<0.05	1	11	0.1	<0.5	6	0.1	<0.5
Total reversible onchocercal skin disease	442	0.3	68	130	0.2	21	67	0.4	11	32	0.7	5
Mild depigmentation	366	0.3	4	274	0.4	3	174	1	2	65	1.4	1
Severe depigmentation	277	0.2	18	233	0.3	15	238	1.3	15	115	2.4	7
Atrophy	<0.5	<0.05	<0.5	<0.5	<0.05	<0.5	<0.5	<0.05	<0.5	<0.5	<0.05	<0.5
Hanging groin	<0.5	<0.05	<0.5	1	<0.05	<0.5	6	<0.05	2	8	0.2	3
Total irreversible onchocercal skin disease	643	0.4	22	508	0.8	18	418	2.3	20	188	4	11
Total onchocercal skin disease*	1,566	1.1	95	1,057	1.6	43	765	4.2	33	451	9.5	18
Visual impairment	192	0.1	6	69	0.1	2	38	0.2	1	17	0.3	1
Blindness	34	<0.05	227	10	<0.05	74	14	0.1	102	11	0.2	87
Total onchocercal eye disease	226	0.2	233	80	0.1	77	51	0.3	103	27	0.6	87
Total all manifestations	1,792	1.2	329	1,137	1.7	120	817	4.5	137	478	10.1	106

* Note: Total onchocercal skin disease is the sum of palpable nodules, reversible and irreversible skin disease.